NPR would like to hear from you. With the future of some abortion pills in jeopardy, tell us about your experience using medication to end a pregnancy or treat a miscarriage.
A U.S. appeals court ruling ratchets approval of the abortion pill mifepristone from 10 weeks of pregnancy down to seven weeks and says that — for now — the drug can no longer be sent in the mail.
The end-of-life benefit costs billions a year. A new approach aims to eliminate waste and weed out bad actors, while making the care more inviting to those who most need it.
The Department of Health and Human Services will propose an amended definition of "lawful presence" to include recipients of the Deferred Action for Childhood Arrivals program, the White House said.
A federal appeals court will allow partial access to the abortion drug mifepristone while a high-profile federal case plays out, but with new limitations on how the drug can be dispensed.
A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail.
The start of pregnancy — as well as exactly when that happens — is a hot topic in some state legislatures and U.S. courts. Understanding the nuances of what happens when has never been more important.
The mifepristone ruling in Texas has been met with concern from the pharmaceutical industry, who say the decision, if upheld, could having a chilling effect on the development of new drugs.